Remedent, Inc Reports Financial Results for the First Quarter Ended June 30, 2017
August 15, 2017
Share
Remedent, Inc. reported financial results for the first quarter ended June 30, 2017. For the quarter, the company's net sales increased by approximately 28.5% to $791,339 as compared to $615,949 for the three months ended June 30, 2016. The increase in sales is primarily due to recent launch of Condor 3D Scanner in the North American market. Net income attributable to the company's shareholders was $62,431 down approximately 38.4% from $101,415 for the three months ended June 30, 2016.
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
REMEDENT, INC. 